Daniel Joseph McCarthy - Nov 15, 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
PRESIDENT
Signature
/s/ Jonathan Weinberg. Attorney-in-fact
Stock symbol
EVH
Transactions as of
Nov 15, 2023
Transactions value $
-$298,050
Form type
4
Date filed
11/20/2023, 08:01 AM
Previous filing
Jun 14, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Sale -$120K -4K -1.94% $30.00 202K Nov 15, 2023 Direct F1, F2
transaction EVH Class A Common Stock Sale -$120K -4K -1.98% $30.00 198K Nov 15, 2023 Direct F1, F2
transaction EVH Class A Common Stock Options Exercise $32K +3K +1.51% $10.65 201K Nov 15, 2023 Direct F1, F2
transaction EVH Class A Common Stock Sale -$90K -3K -1.49% $30.00 198K Nov 15, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Option (right to buy) Options Exercise $0 -3K -100% $0.00* 0 Nov 15, 2023 Class A Common Stock 3K $10.65 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on May 12, 2019.